Verus Financial Partners, Inc. Abb Vie Inc. Transaction History
Verus Financial Partners, Inc.
- $896 Million
- Q4 2024
A detailed history of Verus Financial Partners, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Verus Financial Partners, Inc. holds 3,485 shares of ABBV stock, worth $593,495. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,485
Previous 3,479
0.17%
Holding current value
$593,495
Previous $687,000
9.9%
% of portfolio
0.07%
Previous 0.08%
Shares
29 transactions
Others Institutions Holding ABBV
# of Institutions
3,870Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$29.2 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.2 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.5 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$8.91 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.59 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $301B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...